Novo Integrated Sciences Total Depreciation and Amortization - Cash Flow 2012-2024 | NVOS
Novo Integrated Sciences total depreciation and amortization - cash flow from 2012 to 2024. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
Novo Integrated Sciences Annual Total Depreciation and Amortization - Cash Flow
(Millions of US $) |
| 2024 |
$9 |
| 2023 |
$7 |
| 2022 |
$9 |
| 2021 |
$2 |
| 2020 |
$1 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$0 |
| 2016 |
$N/A |
| 2016 |
$0 |
| 2015 |
$2 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2011 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
